GNA Biosolutions

About:

GNA Biosolutions is a private molecular diagnostics company.

Website: https://www.gna-bio.com/

Twitter/X: gnabiosolutions

Top Investors: KfW, Bosch Ventures, OCCIDENT, SHS Capital, UVC Partners

Description:

GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Munich, Bayern, Germany

Founded Date:

2010-06-22

Founders:

Federico Bursgens, Joachim Stehr, Lars Ullerich

Number of Employees:

11-50

Last Funding Date:

2019-08-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai